Last reviewed · How we verify
jinghua weikang capsule
At a glance
| Generic name | jinghua weikang capsule |
|---|---|
| Sponsor | The First Affiliated Hospital of Dalian Medical University |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Jinghua Weikang Capsule in the Treatment of Reflux Esophagitis (PHASE4)
- Jinghua Weikang Capsule Containing Quadruple Therapy for IgAN With Helicobacter Pylori Infection (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: